Patterns of Epithelial Cell Invasion by Different Species of the Burkholderia cepacia Complex in Well-Differentiated Human Airway Epithelia by Schwab, U. et al.
INFECTION AND IMMUNITY, Aug. 2002, p. 4547–4555 Vol. 70, No. 8
0019-9567/02/$04.000 DOI: 10.1128/IAI.70.8.4547–4555.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Patterns of Epithelial Cell Invasion by Different Species of the
Burkholderia cepacia Complex in Well-Differentiated Human
Airway Epithelia
Ute Schwab,1* Margaret Leigh,1 Carla Ribeiro,1 James Yankaskas,1 Kimberly Burns,1
Peter Gilligan,1 Pamela Sokol,2 and Richard Boucher1
Cystic Fibrosis/Pulmonary Research and Treatment Center, The University of North Carolina at Chapel Hill, Chapel
Hill, North Carolina 27599-7248,1 and Department of Microbiology and Infectious Diseases, University of Calgary
Health Sciences Center, Calgary, Alberta, Canada T2N 4N12
Received 25 February 2002/Returned for modification 2 April 2002/Accepted 8 May 2002
Burkholderia cepacia has emerged as a serious respiratory pathogen in cystic fibrosis (CF) patients. The
clinical course of B. cepacia infections is variable, but 20% of patients eventually succumb to the cepacia
syndrome, which is characterized as a fatal necrotizing pneumonia with bacteremia. The mechanisms that
permit B. cepacia to cause bacteremia are not yet known but probably involve sequential penetration of airway
barriers. This study evaluated the abilities of different species of the B. cepacia complex, including a strain from
the ET12 lineage (BC-7, genomovar III, cblA), which is associated with most cepacia syndrome fatalities
among CF populations, a genomovar IV strain (HI2258), and a genomovar II strain (J-1) to penetrate
polarized, well-differentiated human airway epithelial cell cultures. As revealed by light and electron micros-
copy, all three B. cepacia strains tested circumvented the mechanical barriers of mucus and ciliary transport
to penetrate the airway epithelium but they used different routes. The BC-7 strain (genomovar III) formed
biofilms in close proximity to the apical cell surface, followed by invasion and destruction of epithelial cells.
This process involved disruption of the glycocalyx and rearrangements of the actin cytoskeleton. The HI2258
strain (genomovar IV) did not form biofilms, and the majority of bacteria that penetrated the epithelium were
located between epithelial cells, suggesting paracytosis. Strain J-1 penetrated the epithelium both by cell
destruction and paracytosis. These studies suggest that the distinct invasion pathways employed by B. cepacia
may account for differences in virulence between B. cepacia genomovars.
In cystic fibrosis (CF), chronic bacterial infection results in
bronchiectasis and ultimately respiratory failure. The initial
infective organisms may include Haemophilus influenzae and
Staphylococcus aureus. Then, chronic persistent infections with
mucoid strains of Pseudomonas aeruginosa develop in the ma-
jority of CF patients (5, 8, 12). Despite chronic infections with
these organisms, necrotizing pneumonia and bacteremia are
rare occurrences in CF. Recently, Burkholderia cepacia has
emerged as an important pathogen for CF patients (9). Al-
though not as prevalent as P. aeruginosa, B. cepacia can be
isolated from as many as 13.3% of CF patients (Cystic Fibrosis
Foundation Patient Registry, Annual data report, 2000: all
cystic fibrosis patients currently under care at 117 CF care
centers in the United States, 2001), and highly transmissible
strains have been reported (32). Most patients harboring B.
cepacia exhibit a chronic infection associated with periods of
acute exacerbations. Importantly, 20% of patients harboring
B. cepacia eventually succumb to the cepacia syndrome, a rap-
idly fatal clinical deterioration with acute necrotizing pneumo-
nia and bacteremia (13). Up to nine genomovars are known to
occur in CF patients (4, 34). Of these, genomovar III strains
occur in approximately 50% of CF patients infected with B.
cepacia and are associated with most cases of cepacia syn-
drome (18).
The mechanism(s) that permits B. cepacia to cause chronic
versus invasive infections with bacteremia is not yet known.
One possibility is that, during chronic infection, B. cepacia
forms biofilms confined to the intraluminal mucus layer. This
notion is supported in part by the observation that B. cepacia
is able to form biofilms in vitro (2, 6, 11, 22, 25), and an
outbreak of B. cepacia in hemodialysis patients has been re-
ported to result from biofilm-forming organisms in catheters
(15). In addition Nielsen et al. (22) showed that both P. aerugi-
nosa and B. cepacia grown in flow chambers formed coaggre-
gated or single-species biofilms depending on growth condi-
tions, suggesting that P. aeruginosa and B. cepacia may coexist
in CF airways. However, localization of B. cepacia to intralu-
minal mucus in CF lungs has yet not been reported.
In contrast, it appears likely that invasion and bacteremia
are associated with penetration of airway epithelia and trans-
mission via macrophages. For example, several investigators
have shown that B. cepacia can survive in A549 human epithe-
lial cells and macrophages (3, 16, 19, 26). Recently, B. cepacia
has been localized by immunohistology in patients with cepacia
syndrome in the exudates within bronchial lumens and be-
tween airway epithelial cells (27). These CF patients were
infected by the transmissible clonal ET12 (Edinburgh-To-
ronto) lineage belonging to genomovar III. The isolates of this
clone carry the cblA gene, which encodes the major subunit for
surface cable pili, which have been shown to mediate binding
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to respiratory mucins (28), and thus may facilitate invasion by
this bacterium. It is not known whether the immunohistologi-
cal findings in the report of Sajjan et al. (27) represent features
characteristic of this ET12 strain or of late-stage pulmonary
infection with B. cepacia in general.
In the present study, we examined different species of the B.
cepacia complex invasion pathways in well-differentiated hu-
man airway epithelial cell cultures. In this in vitro model sys-
tem, we tested whether different strains of B. cepacia devel-
oped different invasion pathways, i.e., biofilm formation
associated with invasion, single-cell entry, and/or paracytosis.
In addition, we asked whether biofilm-mediated invasion in-
volved glycocalyx disruption and rearrangement of the actin
filaments on the apical cell surface.
MATERIALS AND METHODS
Human airway epithelial cell cultures. Well-differentiated human airway ep-
ithelial cell cultures were grown on Costar (Cambridge, Mass.) 12-mm-diameter
Transwell-Col (T-Col) supports as previously described (1). Cells were removed
by protease dissociation from portions of the main stem or lobar bronchi from
excess donor tissue obtained at the time of lung transplantation under the
auspices of the University of North Carolina Institutional Committee on the
Protection of The Rights of Human Subjects. Dissociated primary airway epi-
thelial cells were grown on 100-mm-diameter tissue culture dishes in bronchial
epithelial culture (BEC) medium. Passage 2 cells were seeded on the T-Col
membrane supports (Costar) under air-liquid interface conditions at a density of
about 106 cells/cm2 and were grown in BEC medium modified from that in
reference 1 by the use of LHC basal medium–high-glucose Dulbecco’s modified
Eagle’s medium (1:1) and bovine pituitary extract (10 mg/liter; Upstate Biotech-
nology, Inc., Lake Placid, N.Y.) in the absence of antibiotics. When the cultures
reached confluence (5 days), only the medium in the serosal chamber was
replaced. Epithelial cell cultures were studied 2 to 4 weeks after achieving
confluence when they were fully differentiated into ciliated and mucus-producing
cells (determined by light microscopy).
Bacterial strains and growth conditions. The following B. cepacia strains were
analyzed for their abilities to invade airway epithelial cultures: BC-7 (genomovar
III, cblA major CF lineage ET12; provided by Richard Goldstein, Boston
University), J-1 (Burkholderia multivorans, genomovar II; provided by Peter
Gilligan), HI2258 (Burkholderia stabilis, genomovar IV; provided by John
LiPuma, Michigan University), and K56-2 (genomovar III, cblA major CF
lineage ET12; provided by Pamela Sokol) and its derivative K56-I2, which does
not produce N-acylhomoserine lactones (cepI::tmp [17]; provided by Pamela
Sokol). Strains HI2258 and J-1 were isolates from CF patients without bactere-
mic infection. Stocks of the bacteria were kept at 70°C in skim milk. For all
studies, bacteria were grown at 37°C on sheep blood agar plates.
Infection of airway epithelial cell cultures. For infection of airway epithelial
cell cultures, several colonies of B. cepacia grown overnight on agar plates were
inoculated into 5 ml of BEC medium and grown for 6 to 8 h to reach an optical
density at 470 nm of 0.25. The suspension was pelleted and resuspended in 200
l of medium, and 50 l was directly transferred to the apical cell surfaces of the
airway epithelial cell cultures. In some experiments the bacterial suspension was
diluted 1:100 prior to infection of the airway epithelium. The inoculum size was
determined for each infection by serial dilutions and plating and ranged between
approximately 4  107 to 6  107 CFU/50 l and 4  105 to 6  105 CFU/50 l
when the suspension was diluted 1:100. We used log phase bacteria, since it is not
yet clear whether the organisms are in log or stationary phase during acquisition
of infection, which is the stage of the infection process that we have investigated.
To confirm the functional integrity of the epithelial cell layers, transepithelial
resistance (Rt) was measured with an EVOM epithelial volt-ohmmeter (World
Precision Instruments, Berlin, Germany).
Pretreatment of bacteria. To test whether viability was required for epithelium
penetration, we infected airway epithelial cell cultures with either killed organ-
isms or live organisms at an inoculum of 5  107 CFU/50 l. Two methods
were used to kill bacteria. In the first, bacteria were exposed to UV light for 15
min. In the second method, bacteria were exposed to 56°C for 40 min. For both
methods, bacteria were pelleted and resuspended in 200 l of culture medium
and 50 l of this suspension was transferred to the mucus layer of airway
epithelial cell cultures. Both treatments reduced the number of viable organisms
to 10 CFU/50 l.
Preparation of infected airway epithelial cell cultures for light, scanning, and
electron microscopy. Infected and noninfected epithelial cell cultures were
fixed with 1% OsO4-perfluorocarbon for 30 min, a fixation method which
does not perturb the airway surface liquid layer (see Fig. 1A) (20). For light
microscopy (LM), the fixed cultures were embedded in epoxy and sectioned.
Semithin sections from the center of the cell culture preparation were stained
with Richardson’s stain. The following characteristics were determined in
sections encompassing the overall length of airway epithelial cell cultures (12
mm): presence of biofilms, single bacteria found between cells or within cells,
and damage of the airway epithelium, evaluated as mild, moderate, or severe.
For transmission electron microscopy (TEM), ultrathin sections (90 nm) were
cut from blocks and mounted on grids and stained with uranyl acetate and
lead citrate and areas of interest were examined with an electron microscope.
For scanning electron microscopy (SEM), the cultures were fixed with 4%
paraformaldehyde for 10 min and postfixed in 1% OsO4 prior to dehydration
through a graded ethanol series. After being coated with gold-palladium the
specimens were viewed by SEM.
Immunohistology. Infected and noninfected airway epithelial cell cultures
were fixed in 4% paraformaldehyde for 15 min and washed in phosphate-buff-
ered saline (PBS). Paraffin-embedded sections were cut, deparaffinized by xylene
treatment, rehydrated in graded alcohols, washed in PBS, and then incubated
with different dilutions of the rabbit antiserum specific for the B. cepacia complex
(Heiner Neubauer, FAF Medical Academy, Institute of Microbiology, Munich,
Germany) or normal rabbit serum (negative control). Afterwards, we added
sequentially the secondary antibody (biotinylated goat anti-rabbit immunoglob-
ulin G; diluted 1:250), streptavidin-horseradish peroxidase conjugate reagent,
and the substrate, diaminobenzidine tetrahydrochloride. The sections were coun-
terstained with light green and examined by LM. The strongest signal was
obtained by using the B. cepacia antiserum at a 1:500 dilution, and this dilution
was used for all infected cultures.
Apical cell surface glycocalyx staining. Ruthenium red oxychloride is an in-
organic, synthetically prepared, intensely colored crystalline compound that dis-
plays a high affinity for sulfated mucopolysaccharides, chondroitin sulfate, hepa-
ran sulfate, and keratan sulfate (23). Because of its size, ruthenium red does not
penetrate undamaged plasma membranes. To assess the integrity of the glyco-
calyx in infected airway epithelial cell cultures, cultures were immersed in 4%
glutaraldehyde containing 1,500 ppm ruthenium red (10). After being rinsed in
0.1 M cacodylate buffer, the tissues underwent immersion fixation in a solution
of 5% osmium tetroxide containing 1,500 ppm ruthenium red for 3 h. Specimens
were then dehydrated and embedded in Epon. Semithin sections stained with
Richardson’s stain were analyzed for areas of the epithelium associated with
bacterial biofilms closely associated with the apical cell surface. Ultrathin sec-
tions (90 nm) of these areas were then stained with uranyl acetate and lead
citrate and examined by TEM.
Fluorescent staining of B. cepacia and the actin cytoskeleton in well-differen-
tiated human airway epithelial cell cultures for confocal microscopy. An immu-
nofluorescence staining protocol modified from a previously published method
(24) was used. Noninfected and B. cepacia (5  107 CFU/airway epithelial cell
culture for 24 h)-infected airway epithelial cell cultures were fixed with 4%
paraformaldehyde for 15 min, washed in PBS, and permeabilized with 1% Triton
X-100. The cultures were then blocked overnight with 3% bovine serum albumin,
and infected cultures were incubated for 1 h at 37°C with rabbit antiserum (1:250
dilution) specific for the B. cepacia complex, followed by incubation with a goat
anti-rabbit fluorescein isothiocyanate-conjugated antibody. For the labeling of
the actin cytoskeleton, the immunostained and the noninfected airway epithelial
cell cultures were then incubated with BODIPY-phalloidin (Molecular Probes
Inc., Eugene, Oreg.) at a 1:25 dilution for 30 min at 25°C (24). Airway cell
cultures were then rinsed with PBS and visualized by confocal microscopy (Leica;
model TCS 4D confocal microscope; PL APO 63/NA1.2 water lens).
Quantification of bacteria in mucus of infected airway epithelial cell cultures.
Airway epithelial cell cultures were inoculated with 5  105 CFU of the different
strains of B. cepacia in parallel experiments for 24, 36, and 48 h. In one set of
experiments, the mucus from one culture was harvested by lavage with PBS
containing 10 mM dithiothreitol (DTT; Sigma Chemical Co., St. Louis, Mo.) at
24, 36, and 48 h for quantification of bacterial number. In preliminary experi-
ments we could show that DTT at this concentration did not affect bacterial
viability. The numbers of bacteria in the fractions harvested with DTT were
determined by serial dilution and plating on sheep blood agar plates. For a
second set of experiments, we fixed the culture with 1% OsO4-perfluorocarbon
to examine the mucus layer for formed biofilms.
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RESULTS
Biofilm-dependent invasion of B. cepacia BC-7 (genomovar
III, cblA major CF lineage ET12). To determine if B. cepacia
BC-7 invades the airway wall, we infected well-differentiated
human airway epithelial cell cultures that contained superficial
(lumen-facing) and basal epithelial cells (Fig. 1A). This super-
ficial epithelial cell layer contained ciliated and secretory cells
that produce mucus in quantities mimicking in vivo conditions.
After a 24-h incubation with 5  107 CFU log phase bacteria
of strain BC-7, a few planktonic (single) bacteria were seen in
the mucous layer but the majority of bacteria formed aggre-
gates in the mucus layer when analyzed by LM (Fig. 1B) and
SEM (Fig. 1C). These aggregates formed in close proximity to
the apical surface of cells in defined regions and showed some
of the characteristics of a typical biofilm: (i) they had a distinct
boundary, (ii) they were attached to a surface, and (iii) the
bacteria appeared to be buried in the residue of their glycoca-
lyx (Fig. 1D). The number of biofilms per section ranged be-
tween 2 and 12.
Several other features of these biofilms were noteworthy. In
all cultures infected with BC-7, biofilms were formed but they
appeared to be in different stages of development. In addition
to the smaller biofilms in close proximity to the apical cell
surface (Fig. 1B), larger biofilms either at an early (Fig. 2B) or
late stage (Fig. 2A) of penetration were observed. Interest-
ingly, even though moderate-to-severe tissue damage of the
superficial epithelial cell layer occurred when larger biofilms
penetrated tissues, the basal cell layer remained intact in these
infected cultures (Fig. 2B). When areas of epithelia subjacent
to such biofilms were analyzed by TEM, intracellular (Fig. 2C)
and intercellular (Fig. 2D) bacteria were found only in epithe-
lial cells associated with biofilms, suggesting that biofilm for-
mation facilitated invasion into the epithelium. This biofilm-
dependent invasion pathway seems to be the predominant one
used by the BC-7 strain, since we rarely found single bacteria
not associated with biofilms within or between epithelial cells
(Table 1).
Immunostaining and ruthenium red staining of BC-7-in-
fected cultures (Table 1) confirmed our observations of in-
fected tissues stained with Richardson’s stain. Interestingly,
even though the mucus layer was removed by the fixation
methods used for the immunostaining and ruthenium red
staining techniques, densely packed biofilms closely associated
with the epithelium were still detectable, suggesting that these
biofilms are tightly attached to epithelial cells.
When cultures were infected with 5  107 CFU of UV-
irradiated or heat-killed bacteria for 24 h, no invading biofilms
were observed.
FIG. 1. Noninfected and B. cepacia BC-7-infected airway epithelial cell cultures. (A) Well-differentiated human airway epithelial cell culture
grown on a T-Col membrane support for 3 weeks under air-liquid interface conditions and fixed by the perfluorocarbon-osmium tetroxide
technique (20). Semithin sections were stained with Richardson’s stain. Note the preservation of the mucus layer. sl, superficial cell layer; bl, basal
cell layer. (B to D) Small biofilms closely associated with the apical cell surface formed by B. cepacia BC-7 (5  107 CFU/airway epithelial cell
culture) in airway epithelial cell cultures after 24 h of incubation. Cultures were examined by LM (B) (semithin section stained with Richardson’s
stain), SEM (C), and TEM (ultrathin section from ruthenium red-stained culture) (D), which show bacteria being buried in the residue of their
glycocalyx. Arrows (B and C), small biofilm; arrowheads (B), single (planktonic) bacteria.
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Biofilm-independent invasion by B. stabilis HI2258 (geno-
movar IV). To determine whether biofilm-mediated invasion
was a specific feature of the particular BC-7 strain belonging to
genomovar III, cblA major CF lineage ET12, we investigated
whether a different genomovar type, i.e., genomovar IV (B.
stabilis), which is seen in fewer than 5% of infected CF patients
(18), formed biofilms and invaded the tissue by using the same
well-differentiated cell culture preparation.
In contrast to BC-7, the B. stabilis HI2258 strain did not
form biofilms in any of the cultures examined, as determined
by using the different staining methods (Table 1). Instead, this
organism was predominantly located between cells and occa-
sionally within cells in infected well-differentiated cultures
(Fig. 3). No disruption of the integrity of the epithelium was
observed during infection with this strain. Intercellular tight
junctions were observed above single bacteria and clusters,
indicating that the integrity of the epithelia was not damaged
by the bacterial penetration into the epithelium. The integrity
of the tight junctions was further assessed by Rt measurements,
which showed similar values (means  standard errors) for Rt
for noninfected (884  284 /cm2; n 	 3) and HI2258-infected
(747  197 /cm2; n 	 3) cultures. When cultures were in-
fected with 5  107 CFU of UV-irradiated or heat-killed
bacteria for 24 h, no intra- or intercellular bacteria were de-
tected, suggesting that the penetration of this organism into or
between the cells required living cells.
Biofilm-dependent and -independent invasion by B. mul-
tivorans J-1 (genomovar II). When a more common genomovar
type, i.e., genomovar II (B. multivorans), which is seen in about
38% of infected CF patients (18), was tested for invasion of
well-differentiated airway epithelia, it was found that the B.
multivorans J-1 strain appeared to use multiple invasion routes.
This strain invaded the tissue after biofilm formation (one to
six biofilms per section), but it also was detected within and
FIG. 2. Different stages of biofilm development of B. cepacia BC-7 (5  107 CFU/airway epithelial cell culture) in well-differentiated airway
epithelial cell cultures after 24 h of incubation. Large biofilms at late (A) and early (B) stages of penetration were examined by LM (semithin
sections stained with Richardson’s stain; see also Table 1). (C and D) Large biofilm at an early stage of penetration examined by TEM revealing
intracellular (C) and intercellular (D) bacteria (arrowhead) in epithelial cells associated with this biofilm. Note destruction of adjacent epithelial
cells.
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between epithelial cells in areas not associated with biofilms
(data not shown). Quantitative analysis of multiple cultures for
invasion patterns showed that the invasion patterns were seem-
ingly equally distributed (Table 1). Occasionally, J-1 caused
extensive damage of the tissue that included the basal cell
layer. Again, in cultures infected with UV-irradiated or heat-
killed bacteria, no invasion was observed (data not shown).
Biofilm-dependent invasion process involves disruption of
the apical cell surface glycocalyx. Semithin sections of tissue
cultures exposed to 5  107 CFU of B. cepacia BC-7 or
vehicle (24-h incubation) were prepared and examined by LM.
Areas of the epithelium associated with overlying biofilms were
selected and prepared for TEM. In noninfected cultures, the
electron-dense ruthenium red stained a clearly defined 70- to
100-nm-thick glycocalyx on the apical membrane of the airway
epithelium and the cilia (Fig. 4A). In areas of infected cultures
where small biofilms formed and the mucus layer was pre-
served, the bacteria, mucins contained in the mucus layer, and
the cell surface glycocalyx were intensely stained. In some
areas, small biofilms in direct contact with the glycocalyx of
microvilli were observed (Fig. 4B). However, we also observed
bacteria contained within biofilms associated with microvilli on
which the glycocalyx was dramatically reduced. Figure 4C
shows a bacterium binding to a microvillus with the glycocalyx
apparently destroyed, suggesting glycocalyx degradation by the
bacteria within biofilms. In Fig. 4D, individual bacteria within
a biofilm bind to the cell membrane, and the glycocalyx was
absent in regions where this binding occurs. Interestingly, in-
tracellular bacteria were also found selectively in those areas.
In regions not associated with biofilms, we did not detect gly-
cocalyx degradation or bacterial binding. This glycocalyx deg-
radation was also found in J-1-infected cultures in areas asso-
ciated with biofilms but not in cultures infected with HI2258.
Biofilm-dependent invasion process involves disruption of
the actin cytoskeleton. The epithelium beneath biofilms ap-
peared “indented,” suggesting a loss of cytoskeletal function
(Fig. 1B). To determine whether biofilms disrupted the actin
cytoskeleton, we performed confocal microscopy using
BODIPY-phalloidin to specifically label filamentous actin. In
noninfected cultures, the airway epithelium showed intact ac-
tin filaments (Fig. 5A). In contrast, in J-1- and BC-7-infected
cultures immunostained bacteria formed a biofilm-like struc-
ture (Fig. 5B and E) and the actin cytoskeleton in this area was
rearranged (Fig. 5C and F). This notion was confirmed by an
overlay of both signals, demonstrating colocalization of the
bacterial and cytoskeletal stains as a yellow-stained area (Fig.
5D and G), suggesting that the invading biofilm rearranged the
actin cytoskeleton. In contrast, no actin cytoskeletal changes in
HI2258-infected cultures were observed. UV-irradiated and
heat-killed bacteria of strains BC-7 and J-1 did not affect the
actin component of the cytoskeleton (data not shown).
Effect of bacterial density on biofilm formation. To deter-
mine the effect of bacterial growth on biofilm formation, six
airway epithelial cell cultures were infected with 5  105 CFU
of one of the biofilm-forming strains, BC-7 or J1, or the non-
biofilm-forming strain, HI2258, and incubated for 24, 36, and
48 h. In one set of experiments, the mucus from one infected
culture was harvested by PBS-DTT lavage at the appropriate
time points for enumeration of bacteria. For a second set of
experiments, we fixed the infected culture with OsO4-perfluo-
rocarbon to examine the mucus layer for formed biofilms.
All tested B. cepacia strains grew in mucus. As expected,
strain HI2258 did not form biofilms, even after an incubation
of 48 h producing 
108 CFU/airway epithelial cell culture,
whereas strains BC-7 and J-1 formed biofilms after 48 and 36 h
of incubation, respectively, when both bacteria reached a den-
sity of 
108 CFU/airway epithelial cell culture. At shorter
incubation periods, the organisms presumably failed to achieve
the necessary bacterial density to synthesize the products crit-
ical for biofilm formation. Infection of cultures with higher
bacterial numbers (5  107 CFU/airway epithelial cell cul-
ture) required shorter incubation times for developing biofilms
(24 h; Table 1). Of particular clinical relevance, the bacterial
density at which B. cepacia formed biofilms correlated with the
number of bacteria (106 to 108 CFU/ml) found in CF patient
sputa when heavily infected with B. cepacia (Peter Gilligan,
personal communication).
Effect of quorum sensing on biofilm formation. Recently, it
has been shown that biofilm formation by B. cepacia on abiotic
surfaces requires a functional cepIR quorum-sensing system
(11). We asked whether a cepI mutant strain that does not
produce N-acylhomoserine lactones is capable of forming bio-
films in the mucus layers of well-differentiated airway epithelial
TABLE 1. Biofilm-dependent and -independent invasion of B.











BC-7 RS 12 (12) 3 (12) 3 (12)
IS 2 (2) 0 (2) 0 (2)
RR 4 (4) 1 (4) 1 (4)
HI2258 RS 0 (3) 3 (3) 3 (3)
IS 0 (2) 2 (2) 2 (2)
RR 0 (2) 2 (2) 2 (2)
J-1 RS 3 (3) 3 (3) 3 (3)
IS 3 (3) 3 (3) 3 (3)
RR 2 (2) 2 (2) 2 (2)
K56-2 RS 3 (3) 0 (3) 0 (3)
K56-12 RS 3 (3) 0 (3) 0 (3)
a Approximately 5  107 CFU/airway epithelial cell culture for 24 h.
b RS, Richardson staining; IS, immunostaining; RR, ruthenium red staining.
c Numbers in parentheses are total numbers of infected airway cultures.
FIG. 3. Light micrograph of semithin section of a well-differenti-
ated airway epithelial cell culture infected with B. stabilis HI2258 (5
 107 CFU/culture) for 24 h. Note bacteria within and between epi-
thelial cells (see also Table 1).
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cell cultures. Both K56-2 (wild-type) and the cepI mutant strain
formed characteristic biofilms in the mucus layer when 5 
107 bacteria were incubated with the airway epithelium for 24 h
(Table 1). Small biofilms growing in mucus and large biofilms
growing in the epithelium and degrading the epithelial surface
were observed. The number of biofilms per section ranged
between 2 and 13. When lower inocula were used for infection,
both the parent and the mutant strain reached 
108 CFU
within 36 h compared to 48 h required for BC-7. At 36 and 48 h
of incubation, no apparent morphological differences between
biofilms formed by the wild type K56-2 and the mutant K56-I2
strains were observed.
DISCUSSION
Bacterial invasion through the airways and sepsis are not
observed with the major CF pathogens, S. aureus, H. influen-
zae, and P. aeruginosa (8, 12, 30). In contrast, B. cepacia in-
vades airway epithelia and causes sepsis in CF patients. To
evaluate the abilities of different species of the B. cepacia
complex to penetrate airway epithelia, we conducted the
present study of well-differentiated human airway epithelial
cell cultures that reflect closely the morphology and function of
airway epithelia in vivo (20).
Interestingly, all three B. cepacia strains tested invaded air-
way epithelia, but they used different invasion pathways. Strain
BC-7, belonging to the transmissible genomovar III ET12 lin-
eage, predominantly invaded the epithelium by forming bio-
films in mucus that ultimately reached epithelial surfaces (Fig.
1 and 2). Almost all intra- and intercellular organisms of this
strain were found associated with biofilms. Immunolocaliza-
tion studies of CF patient lung tissue infected by strains of the
ET12 lineage showed bacterial clusters in the luminal exudates
within the larger bronchi, some of which were associated with
the epithelial surface (27). Based on our observations, these
bacterial clusters could reflect biofilms growing in mucus that
FIG. 4. TEM of ruthenium red-stained glycocalyx on the apical cell surface of noninfected and BC-7 (5  107 CFU/airway epithelial cell
culture for 24 h)-infected airway epithelial cultures (see also Table 1). (A) Glycocalyx (70 to 100 nm thick) on the apical membrane of a noninfected
airway epithelium including cilia. (B) Bacteria (arrowheads) closely associated with glycocalyx of microvilli. (C) Single bacterium binding to the
extended microvillus with the glycocalyx apparently destroyed. (D) Mature biofilm of BC-7. Note the absence of a glycocalyx on the apical cell
surface of the biofilm-associated airway epithelium.
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extended to the apical cell surface of the epithelium. In addi-
tion, the study of Sajjan et al. (27) also reported bacteria in
surface epithelial cells and between adjacent epithelial cells,
consistent with our findings.
Bacteria that grow in the stationary mucus layer that char-
acterizes CF airway surfaces (20, 36) face a second extracellu-
lar barrier, the glycocalyx, on the apical surface of human
airway epithelial cells. The glycocalyx is composed of carbohy-
drate-rich molecules, including proteoglycans, glycolipids, gly-
coproteins, and, most notably, cell surface (“tethered”) mucins
(1, 21). In BC-7-infected cultures, the glycocalyx matrix was
disrupted in areas where bacteria contained within biofilms
closely associated with the apical cell surface of the epithelium
(Fig. 4D). We observed bacteria closely attached to microvilli
devoid of glycocalyx (Fig. 4C), suggesting that B. cepacia de-
graded the glycocalyx. Of interest, this phenomenon was ob-
served only (i) with bacteria within a biofilm and (ii) in areas
associated with cellular invasion.
Our data suggest a sequence for BC-7 invasion of the airway
epithelium. First, a biofilm forms in stagnant airway mucus.
Interestingly, our results argue for a role for bacterial density
in biofilm formation but argue against the involvement of the
cepIR quorum-sensing system in biofilm formation since an
isolate (K56-I2) of the highly transmissible ET12 lineage with
a mutation in the cepI autoinducer synthase still formed bio-
films. Huber et al. (11) showed by quantitative characterization
of B. cepacia H111 biofilm structures on abiotic surfaces that
the cep quorum-sensing system may not be important for the
FIG. 5. Visualization of B. multivorans J-1 and B. cepacia BC-7 biofilm and structure of filamentous actin in human airway epithelia. Confocal
x-y scans of the apical epithelial domain from noninfected airway epithelia (A) and B. multivorans J-1- (B to D) and B. cepacia BC-7 (E to
G)-infected (5  107 CFU/airway epithelial cell culture for 24 h) airway epithelia. (B and E) B. cepacia biofilm (green); (C and F), actin filaments
(red; note extensive cytoskeletal rearrangements); (D and G) colocalization of green biofilm and red actin filaments seen as yellow-stained area.
For immunostaining noninfected and infected airway epithelial cell cultures were incubated for 1 h at 37°C with B. cepacia antiserum (1:250
dilution), followed by incubation with a goat anti-rabbit fluorescein isothiocyanate (FITC)-conjugated antibody. For labeling the actin cytoskeleton,
the immunostained airway epithelial cell cultures were incubated with BODIPY-phalloidin at a 1:25 dilution for 30 min at 25°C. Airway cultures
were then visualized by confocal microscopy. Bars, 10 (A to D) and 20 m (E to G).
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initial attachment of bacteria to the surface but is essential for
the differentiation of microcolonies, a process that is required
for the development of a mature biofilm. Using our descriptive
techniques we are not able to differentiate between microcolo-
nies and mature biofilms. However, our data indicate that
biofilms formed in mucus rather than on an abiotic surface may
not require the cep quorum-sensing system. Second, BC-7
growing in biofilms can apparently degrade the glycocalyx bar-
rier, which appears to be a precursor to cellular invasion. This
capacity to degrade the mucin-rich glycocalyx is consistent with
previous data. For example, B. cepacia has been shown to
possess mucin-sulfatase activity (14), which renders mucins
susceptible to degradation by bacterial glycosidases and pro-
teinases. B. cepacia can also grow in mucus, suggesting that it
may produce mucin-degrading enzymes to utilize mucins as
carbohydrate and energy resources. Consequently, if B. cepacia
produces mucin-degrading enzymes (31) under biofilm condi-
tions, those same enzymes could also degrade glycocalyx com-
ponents, particularly the tethered mucins (1, 21). Third, the
biofilms formed by B. cepacia BC-7 induced rearrangements in
the actin cytoskeleton. These rearrangements appear to be
associated with a loss of cell structural integrity as the cells
underneath the biofilm appear to “collapse” (Fig. 1B and 2).
At this point we are not yet able to determine which bacterial
factors are responsible for actin cytoskeletal disruption and
whether these factors are produced uniquely under biofilm
conditions. Fourth, following cytoskeletal rearrangements,
there appears to be a frank epithelial necrosis that destroys the
luminal cells but not the basal cells (Fig. 2).
Observations made by other investigators are consistent with
aspects of this scheme. For example, ultrastructural observa-
tions of endoscopic biopsy samples from a Helicobacter pylori-
infected gastric epithelium showed that adherence to the target
cell was initiated by direct contact with the cell surface, leading
to the loss of the glycocalyx layer (7). Thus, it seems that H.
pylori is able to bridge the gastric epithelial barrier, in part by
disrupting the glycocalyx.
The absence of biofilm formation by the B. stabilis HI2258
strain (genomovar IV) in our study is consistent with the data
of Conway and Speert (B. D. Conway and D. P. Speert, ab-
stract from the North American Cystic Fibrosis Conference
2001, abstr. no. 323), who reported that several genomovar IV
strains did not form biofilms on polypropylene surfaces. Con-
sistent with the scheme described above, there was no detect-
able degradation of the glycocalyx and no disruption of the
actin cytoskeleton in the absence of biofilms in HI2258-in-
fected airway epithelial cell cultures. In contrast, the paracy-
tosis route across airway epithelia that we observed for this
strain (Fig. 3) has been reported for bacteria that do not form
biofilms. For example, this route is used by H. influenzae when
passing through cell layers of human lung epithelial cell line
NCI-H292 (35). Although B. stabilis has been recovered from
the respiratory tracts of CF patients, there are no data which
associate this organism with worsening CF pulmonary disease.
The finding of a lack of invasiveness with this organism may be
consistent with this observation.
Strain J-1, belonging to genomovar type II, which is ob-
served in CF patients more often than genomovar IV, formed
biofilms and showed glycocalyx disruption and rearrangements
of the cytoskeleton of epithelial cells associated with biofilms.
Whether biofilm formation is a characteristic feature of geno-
movars III and II, which are the most common genomovar
types in CF in vivo (18), remains to be investigated.
Why B. cepacia causes the cepacia syndrome in 20% of
infected CF patients while, in the majority of infected patients,
B. cepacia persists in the airways is not yet clear. Our data
suggest that the BC-7 and K56-2 strains, which belong to the
ET12 lineage (genomovar III) associated with cepacia syn-
drome (18), have to reach a relatively high density to form
biofilms and invade the tissue. Thus, bacterial growth rate may
play an important role in the virulence of these bacteria. The
fact that strains belonging to the most common genomovar
types associated with sepsis in vivo, genomovars II (29) and III
(18), showed a common invasion pattern with biofilm forma-
tion and epithelial necrosis supports our notion that this inva-
sion pathway may be important in vivo. Consequently, these
studies may help in the development of new strategies for
preventive and/or therapeutic intervention against the factors
that trigger epithelial penetration and sepsis by these microbes.
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